Vivek Ramaswamy
Voorzitter bij
Vermogen: 569 M $ op 31-05-2025
Profiel
Vivek Ramaswamy is een ondernemer en zakenman die Roivant Sciences GmbH, Roivant Sciences, Inc., Campus Venture Network, Inc. en Roivant Sciences Ltd. heeft opgericht en aan het hoofd heeft gestaan van 10 verschillende bedrijven. Momenteel is de heer Ramaswamy uitvoerend voorzitter voor Roivant Sciences Ltd., uitvoerend voorzitter van Roivant Sciences GmbH en uitvoerend voorzitter bij Roivant Sciences, Inc. (beide zijn dochterondernemingen van Roivant Sciences Ltd.) en voorzitter van Montes Archimedes Acquisition Corp. De heer Ramaswamy zit ook in de raad van bestuur van Sumitovant Biopharma, Inc. In zijn vorige loopbaan was de heer Ramaswamy voorzitter bij Arbutus Biopharma Corp. en voorzitter bij Arbutus Biopharma, Inc. (een dochteronderneming van Arbutus Biopharma Corp.), Bestuurder bij Sio Gene Therapies, Inc. en Chief Executive Officer bij Axovant Sciences, Inc. (een dochteronderneming van Sio Gene Therapies, Inc.), President van Campus Venture Network, Inc., Investeringsanalist bij QVT Financial LP en Bestuurder bij Myovant Sciences Ltd. (een dochteronderneming van Sio Gene Therapies, Inc.). Hij is afgestudeerd aan de Yale Law School en behaalde een bachelorgraad aan Harvard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-06-2025 | 51.784.238 ( 7,26% ) | 569 M $ | 31-05-2025 |
Laatste nieuws over Vivek Ramaswamy
Actieve functies van Vivek Ramaswamy
| Bedrijven | Functie | Begin |
|---|---|---|
Strive Asset Management LLC
 Strive Asset Management LLC Investment ManagersFinance The company, co-founded by Vivek Ramaswamy and Anson Frericks in 2022, is based in Dublin, OH. Part of Strive Enterprises, Inc., Strive Asset Management LLC is a US-based asset management firm that aims to restore the voices of everyday citizens in the American economy by leading companies to prioritize excellence over politics. Strive Asset Management LLC plans to compete with the world's largest asset managers by launching index funds that promote excellence capitalism across corporate sectors. Matthew Cole has been the CEO of the company since 2022. | Voorzitter | 01-01-2022 |
Eerdere bekende functies van Vivek Ramaswamy
| Bedrijven | Functie | Einde |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Algemeen Directeur | 01-01-2021 |
| ROIVANT SCIENCES LTD. | Algemeen Directeur | 01-01-2021 |
| MYOVANT SCIENCES LTD. | Voorzitter | 07-11-2018 |
| ARBUTUS BIOPHARMA CORPORATION | Voorzitter | 26-11-2018 |
| SIO GENE THERAPIES INC. | Algemeen Directeur | 07-04-2017 |
Opleiding van Vivek Ramaswamy
Yale Law School | Graduate Degree |
Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| ROIVANT SCIENCES LTD. | Health Technology |
| Bedrijven in privébezit | 11 |
|---|---|
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP (QVT Financial) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Finance |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Campus Venture Network, Inc.
 Campus Venture Network, Inc. Internet Software/ServicesTechnology Services Campus Venture Network, Inc. operates a website. The private company is based in Cary, NC. The company was founded by S. Travis May, Vivek Ramaswamy. | Technology Services |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Health Technology |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
Strive Asset Management LLC
Strive Asset Management LLC Investment ManagersFinance The company, co-founded by Vivek Ramaswamy and Anson Frericks in 2022, is based in Dublin, OH. Part of Strive Enterprises, Inc., Strive Asset Management LLC is a US-based asset management firm that aims to restore the voices of everyday citizens in the American economy by leading companies to prioritize excellence over politics. Strive Asset Management LLC plans to compete with the world's largest asset managers by launching index funds that promote excellence capitalism across corporate sectors. Matthew Cole has been the CEO of the company since 2022. | Finance |
Strive Enterprises, Inc.
 Strive Enterprises, Inc. Investment ManagersFinance Strive Enterprises, Inc. manufactures and exports physiotherapy, surgical, healthcare, laparoscopy, beauty, and O.T equipment. The company is based in Columbus, OH and has subsidiaries in the United States. The company was founded by Vivek Ramaswamy. The CEO is Matthew Cole. | Finance |
